The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.

• Status: Completed
• Trial end date: 2015-02-01

Summary

This phase IV multi-centre, randomised, double-blind, placebo-controlled, parallel-group, single-dose study will assess the efficacy and tolerability of the active tablets versus placebo in participants suffering from cold and influenza. Eligible participants will be randomly assigned to one of 2 treatment groups (active or placebo tablets) and enter a four-hour (hr) treatment phase. Each participant will be administered only once during each study period. Participants will use a questionnaire to record the symptom severity scores as described, as well as time.

• Phase: Phase 4

Details

• Lead Sponsor: GlaxoSmithKline
• Collaborator: Sino-American Tianjin Smith Kline & French Laboratories Ltd
• Treatments: Acetaminophen; Chlorpheniramine; Dextromethorphan; Ephedrine; Maleic acid; Pseudoephedrine